India seeks pharma firms partnership to develop indigenous Nipah virus antibody

India seeks pharma firms partnership to develop indigenous Nipah virus antibody

This move aims to establish an indigenous supply, moving away from current imports and scaling up production to a mandated minimum of 1 lakh doses per week.

ICMR seeks industry tie-ups to develop indigenous therapy against Nipah virus

New Delhi, Nov 1 (PTI) The ICMR has sought collaboration with Indian industry partners for manufacturing indigenously developed monoclonal antibodies for treating deadly Nipah Virus following the successful animal trials to ensure their timely access during outbreaks. Monoclonal antibodies are laboratory-made proteins that mimic the antibodies produced by the immune system to protect against foreign substances and harmful pathogens. The Nipah vi…